Silicon Laboratories Inc.

Condensed Consolidated Balance Sheets 

(In thousands, except per share data) 

(Unaudited)

September 28,
2024

December 30,
2023

Assets

Current assets:

   Cash and cash equivalents

$           303,082

$           227,504

   Short-term investments

66,596

211,720

   Accounts receivable, net

48,879

29,295

   Inventories

139,489

194,295

   Prepaid expenses and other current assets

56,090

75,117

Total current assets

614,136

737,931

Property and equipment, net

135,317

145,890

Goodwill

376,389

376,389

Other intangible assets, net

41,936

59,533

Other assets, net

81,464

123,313

Total assets

$        1,249,242

$        1,443,056

Liabilities and Stockholders' Equity

Current liabilities:

   Accounts payable

$             44,648

$             57,498

   Revolving line of credit

—

45,000

   Deferred revenue and returns liability

8,478

2,117

   Other current liabilities

65,179

58,955

Total current liabilities

118,305

163,570

Other non-current liabilities

49,551

70,804

Total liabilities

167,856

234,374

Commitments and contingencies

Stockholders' equity:

   Preferred stock – $0.0001 par value; 10,000 shares authorized; no shares issued

—

—

   Common stock – $0.0001 par value; 250,000 shares authorized; 32,343 and 31,897
   shares issued and outstanding at September 28, 2024 and December 30, 2023,
   respectively

3

3

   Additional paid-in capital

55,567

16,973

   Retained earnings

1,025,544

1,192,731

   Accumulated other comprehensive income (loss)

272

(1,025)

Total stockholders' equity

1,081,386

1,208,682

Total liabilities and stockholders' equity

$        1,249,242

$        1,443,056